Conclusions
TCM AP treatment for 12 weeks leads to a general attenuation of menopausal symptoms, including a substantial reduction in hot flush severity (>60%) in postmenopausal women. This treatment type is found to be superior to sham AP and verum CHM. The former does not differ from placebo CHM. Owing to the small sample size, the generalizability of our results is limited. Our pilot data, however, support the feasibility of conducting a large-scale multicenter trial to validate the preliminary findings.